# $eton Biotech companies are gearing up for significant FDA decisions in February, with $ETON's ET-600 for central diabetes insipidus scheduled for review on February 25th. This PDUFA date could be a major catalyst for the company. ### About $eton $ETON refers to a specific cryptocurrency or digital asset. ### Top $eton Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "watching #1 $SHPH #2 $CRVS#3 $IBRX#4 $CCHH#5 $SOWG #6 $TBMC#7 $THH#8 $POLA #9 $TII #10 $IVF#11 $TWG $HOOK $MAMO $ARHS $ITCI $GLXG $AKYA $IVDA $BBCP $PRZO $OCS $OPFI $LFVN $LIXT $RPRX $SONM $USGO $SWVL $SPCB $ISPO $ETON $MASS $SVV $CING $SERV $WOK $AI $WLDS $MRNA $MCRB $FSLR $ZENA: Base Breakout Setup Developing 🚨📈 ZenaTech Inc. is carving out a constructive base to breakout structure after a prolonged downtrend and multi montHS consolidation. Price has been putting in higher lows and is now attempting to reclaim key resistance levels https://t.co/jwvy3fvJT9 $ZENA: Base Breakout Setup" [X Link](https://x.com/ChirpSavvy/status/2016967588496990394) [@ChirpSavvy](/creator/x/ChirpSavvy) 2026-01-29T20:12Z [---] followers, [---] engagements "February Biotech PDUFA Pulse: 📡 Whats on the FDA Radar Feb [--] $RGNX RGX-121 (MPS II / Hunter syndrome) Priority Review Feb [--] $MRK Keytruda (platinum-resistant recurrent ovarian cancer) Priority Review (label expansion) Feb [--] $VNDA Bysanti (bipolar I disorder / schizophrenia) Feb [--] $ETON ET-600 (central diabetes insipidus) Feb [--] $ASND TransCon CNP (achondroplasia) Priority Review Feb [--] $BMRN PALYNZIQ (PKU adolescents) Priority Review (label expansion) See the attached graphic for the full February PDUFA calendar. https://twitter.com/i/web/status/2016215337554083884" [X Link](https://x.com/BiopharmIQ/status/2016215337554083884) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-01-27T18:22Z 28.9K followers, 96.5K engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Biotech companies are gearing up for significant FDA decisions in February, with $ETON's ET-600 for central diabetes insipidus scheduled for review on February 25th. This PDUFA date could be a major catalyst for the company.
$ETON refers to a specific cryptocurrency or digital asset.
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"watching #1 $SHPH #2 $CRVS#3 $IBRX#4 $CCHH#5 $SOWG #6 $TBMC#7 $THH#8 $POLA #9 $TII #10 $IVF#11 $TWG $HOOK $MAMO $ARHS $ITCI $GLXG $AKYA $IVDA $BBCP $PRZO $OCS $OPFI $LFVN $LIXT $RPRX $SONM $USGO $SWVL $SPCB $ISPO $ETON $MASS $SVV $CING $SERV $WOK $AI $WLDS $MRNA $MCRB $FSLR $ZENA: Base Breakout Setup Developing 🚨📈 ZenaTech Inc. is carving out a constructive base to breakout structure after a prolonged downtrend and multi montHS consolidation. Price has been putting in higher lows and is now attempting to reclaim key resistance levels https://t.co/jwvy3fvJT9 $ZENA: Base Breakout Setup"
X Link @ChirpSavvy 2026-01-29T20:12Z [---] followers, [---] engagements
"February Biotech PDUFA Pulse: 📡 Whats on the FDA Radar Feb [--] $RGNX RGX-121 (MPS II / Hunter syndrome) Priority Review Feb [--] $MRK Keytruda (platinum-resistant recurrent ovarian cancer) Priority Review (label expansion) Feb [--] $VNDA Bysanti (bipolar I disorder / schizophrenia) Feb [--] $ETON ET-600 (central diabetes insipidus) Feb [--] $ASND TransCon CNP (achondroplasia) Priority Review Feb [--] $BMRN PALYNZIQ (PKU adolescents) Priority Review (label expansion) See the attached graphic for the full February PDUFA calendar. https://twitter.com/i/web/status/2016215337554083884"
X Link @BiopharmIQ 2026-01-27T18:22Z 28.9K followers, 96.5K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$eton